From June 19th to 21st, the 22nd CPHI China 2024 (World Pharmaceutical Ingredients China Exhibition) was successfully held in Shanghai, with over 60,000 customers from more than 150 countries attending the exhibition. Xu Hua, Vice President of Tianjin Pharmaceutical Group, Secretary of the Party Committee and Chairman of Tianjin Pharma, Li Shuxiang, Deputy Secretary of the Party Committee and General Manager of Tianjin Pharma, and Deputy General Manager Yang Xiaoyan led the team to participate in the exhibition. Tianjin Pharma was honored with the "CPHI China Pharmaceutical Internationalization Leading Enterprise Award".

As the top event in the international field of pharmaceutical raw materials, CPHI Exhibition attracts industry leaders, experts, scholars and business representatives from around the world, builds an international platform for exchanges of various innovative pharmaceutical products and technologies, and promotes the progress of the pharmaceutical industry.

In order to recognize companies that are determined to forge ahead, continuously innovate and make outstanding contributions in the industry, CPHI & PMEC China grandly held the "CPHI Celebration Awards & Networking Party" on June 19. At the meeting, Tianjin Pharma won the "CPHI China Leading Enterprise Award in Internationalization of Chinese Medicine".

During this period, a variety of products of Tianjin Pharma were exhibited at the booth, showcasing high-quality API products and breakthroughs in technological innovation. The Company's team actively communicated with global business partners on the trade situation, industry future, market status, R&D directions, etc., to discuss development.

The booth attracted many customers. The Company had conducted in-depth and fruitful negotiations with more than 300 new and old customers, reached a number of cooperation intentions, broadened its business channels, and explored new business opportunities.